acquired
Stage
About
Therox developed SuperSaturated Oxygen (SSO2) therapy designed to complement percutaneous coronary intervention (PCI) in improving treatment outcomes for cardiovascular patients.
Explore Therox's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.